INS and type 2 diabetes mellitus: In another multicenter study by Umpierrez et al. involving 130 non-surgical, insulin-naive type 2 diabetes inpatients, the safety and efficacy of the basal-bolus regimen with once-daily glargine and pre-meal glulisine were compared to a SSI regimen.